{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:44:09Z","timestamp":1789343049450,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010248","name":"Zhejiang Province Public Welfare Technology Application Research Project","doi-asserted-by":"publisher","award":["LGF20H16002"],"award-info":[{"award-number":["LGF20H16002"]}],"id":[{"id":"10.13039\/501100010248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BE2023693"],"award-info":[{"award-number":["BE2023693"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270954"],"award-info":[{"award-number":["32270954"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["ZD2022035"],"award-info":[{"award-number":["ZD2022035"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.taap.2025.117340","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:48:03Z","timestamp":1744480083000},"page":"117340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Differences in chemotherapeutic drug sensitivity before and after patient-derived tumor organoid construction"],"prefix":"10.1016","volume":"499","author":[{"given":"Fang","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117340_bb0005","article-title":"Organoids as model for infectious diseases: culture of human and murine stomach organoids and microinjection of Helicobacter Pylori","volume":"105","author":"Bartfeld","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.taap.2025.117340_bb0010","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1038\/s41467-022-30722-9","article-title":"The drug-induced phenotypic landscape of colorectal cancer organoids","volume":"13","author":"Betge","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.taap.2025.117340_bb0015","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.120066","article-title":"Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?","volume":"2","author":"Borst","year":"2012","journal-title":"Open Biol."},{"issue":"5\u20136","key":"10.1016\/j.taap.2025.117340_bb0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drudis.2012.10.003","article-title":"Three-dimensional cell culture: the missing link in drug discovery","volume":"18","author":"Breslin","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.taap.2025.117340_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031349","article-title":"Establishment and long-term expansion of small cell lung cancer patient-derived tumor organoids","volume":"22","author":"Choi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.taap.2025.117340_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107762","article-title":"Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter- and Intrapatient drug responses","volume":"31","author":"de Witte","year":"2020","journal-title":"Cell Rep."},{"issue":"52","key":"10.1016\/j.taap.2025.117340_bb0035","doi-asserted-by":"crossref","first-page":"26580","DOI":"10.1073\/pnas.1911273116","article-title":"Pancreatic cancer organoids recapitulate disease and allow personalized drug screening","volume":"116","author":"Driehuis","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"46","key":"10.1016\/j.taap.2025.117340_bb0040","doi-asserted-by":"crossref","first-page":"18708","DOI":"10.1073\/pnas.1111840108","article-title":"Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance","volume":"108","author":"Gillet","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.taap.2025.117340_bb0045","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djt007","article-title":"The clinical relevance of cancer cell lines","volume":"105","author":"Gillet","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.taap.2025.117340_bb0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11427-023-2423-1","article-title":"Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors","volume":"67","author":"He","year":"2024","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.taap.2025.117340_bb0055","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1038\/s41467-021-22676-1","article-title":"Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.taap.2025.117340_bb0060","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1158\/0008-5472.CAN-08-4808","article-title":"Evidence for cancer stem cells in human endometrial carcinoma","volume":"69","author":"Hubbard","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.taap.2025.117340_bb0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13046-023-02683-4","article-title":"Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study","volume":"42","author":"Jensen","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7\u20138","key":"10.1016\/j.taap.2025.117340_bb0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000516240","article-title":"Animal models in pharmacology: a brief history awarding the Nobel prizes for physiology or medicine","volume":"106","author":"Jota Baptista","year":"2021","journal-title":"Pharmacology"},{"issue":"15","key":"10.1016\/j.taap.2025.117340_bb0075","article-title":"Cross-activity analyses of standard chemotherapy regimens for primary breast cancer using the ATP-based tumor chemosensitivity assay: Pharmacoeconomic implications","volume":"28","author":"Kurbacher","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"7467","key":"10.1016\/j.taap.2025.117340_bb0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.taap.2025.117340_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.taap.2025.117340_bb0090","first-page":"9","article-title":"Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.taap.2025.117340_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40164-021-00246-x","article-title":"Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits","volume":"10","author":"Li","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.taap.2025.117340_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101853","article-title":"LGR5, a prognostic stem cell target, promotes endometrial cancer proliferation through autophagy activation","volume":"40","author":"Li","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.taap.2025.117340_bb0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jocn.2020.04.107","article-title":"Patient-derived tumor organoid predicts drugs response in glioblastoma: a step forward in personalized cancer therapy?","volume":"78","author":"Loong","year":"2020","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.taap.2025.117340_bb0110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nm.3802","article-title":"Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids","volume":"21","author":"Matano","year":"2015","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.taap.2025.117340_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9110146","article-title":"Advances in precision medicine: tailoring individualized therapies","volume":"9","author":"Matchett","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.taap.2025.117340_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082142","article-title":"Metamorphic effect of Angiogenic switch in tumor development: conundrum of tumor angiogenesis toward progression and metastatic potential","volume":"11","author":"Moshe","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.taap.2025.117340_bb0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3892\/ijo.2013.2230","article-title":"Molecular characterization of CD133 cancer stem-like cells in endometrial cancer","volume":"44","author":"Nakamura","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.taap.2025.117340_bb0130","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.celrep.2018.07.001","article-title":"Organoid models of human liver cancers derived from tumor needle biopsies","volume":"24","author":"Nuciforo","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.taap.2025.117340_bb0135","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41467-018-04495-z","article-title":"Patient derived organoids to model rare prostate cancer phenotypes","volume":"9","author":"Puca","year":"2018","journal-title":"Nat. Commun."},{"issue":"7244","key":"10.1016\/j.taap.2025.117340_bb0140","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.taap.2025.117340_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2021.04.008","article-title":"Examining the gut-liver axis in liver cancer using organoid models","volume":"510","author":"Shek","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.taap.2025.117340_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13062-023-00360-2","article-title":"Gene expression in organoids: an expanding horizon","volume":"18","author":"Smirnov","year":"2023","journal-title":"Biol. Direct"},{"key":"10.1016\/j.taap.2025.117340_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102226","article-title":"Patient-derived tumor organoids: a preclinical platform for personalized cancer therapy","volume":"51","author":"Taurin","year":"2025","journal-title":"Transl. Oncol."},{"issue":"7","key":"10.1016\/j.taap.2025.117340_bb0160","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"6444","key":"10.1016\/j.taap.2025.117340_bb0165","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science"},{"issue":"6378","key":"10.1016\/j.taap.2025.117340_bb0170","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.taap.2025.117340_bb0175","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1158\/1078-0432.CCR-19-1872","article-title":"Dual targeting of CDK4\/6 and BCL2 pathways augments tumor response in estrogen receptor-positive breast cancer","volume":"26","author":"Whittle","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.taap.2025.117340_bb0180","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s13402-022-00707-3","article-title":"Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer","volume":"45","author":"Xian","year":"2022","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"1","key":"10.1016\/j.taap.2025.117340_bb0185","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2024.2316085","article-title":"Validation of hyperthermia as an enhancer of chemotherapeutic efficacy: insights from a bladder cancer organoid model","volume":"41","author":"Xu","year":"2024","journal-title":"Int. J. Hyperth."},{"issue":"1","key":"10.1016\/j.taap.2025.117340_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict Chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:49:34Z","timestamp":1762220974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":38,"alternative-id":["S0041008X25001164"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117340","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in chemotherapeutic drug sensitivity before and after patient-derived tumor organoid construction","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117340"}}